Inventor · disambiguated record
Michael D. Winther
Also filed as: WINTHER MICHAEL D · WINTHER MICHAEL DAVID
17 granted patents·12 pending applications·184 citations·filing 1985–2022
92Inventor score
Files withXENON PHARMACEUTICALS INC15ENGINE BIOSCIENCES PTE LTD4ABREO MELWYN2XENON GENETICS INC2BOOTHROYD JOHN C1
Top patents by PatentIndex Score
29 records- 0194US8030488B2Piperazine derivatives as stearoyl-coa desaturase inhibitors and their use as therapeutic agentsXENON PHARMACEUTICALS INC·Filed 2008·Granted Oct 4, 2011·34 cites·28 claims
- 0292US7335658B2Pyridazine derivatives and their use as therapeutic agentsXENON PHARMACEUTICALS INC·Filed 2004·Granted Feb 26, 2008·59 cites·95 claims
- 0390US7390813B1Pyridylpiperazines and aminonicotinamides and their use as therapeutic agentsXENON PHARMACEUTICALS INC·Filed 2002·Granted Jun 24, 2008·35 cites·8 claims
- 0486US7456180B2Piperazine derivatives and their use as therapeutic agentsXENON PHARMACEUTICALS INC·Filed 2004·Granted Nov 25, 2008·24 cites·25 claims
- 0585US7919484B2Combination therapyXENON PHARMACEUTICALS INC·Filed 2006·Granted Apr 5, 2011·10 cites·18 claims
- 0675US7754711B2Pyridazine derivatives and their use as therapeutic agentsXENON PHARMACEUTICALS INC·Filed 2005·Granted Jul 13, 2010·2 cites·6 claims
- 0767US7763618B2Pyridyl derivatives and their use as therapeutic agentsXENON PHARMACEUTICALS INC·Filed 2004·Granted Jul 27, 2010·2 cites·43 claims
- 0866US6759208B2High throughput screening assays using fatty acid synthetic enzymesXENON GENETICS INC·Filed 2002·Granted Jul 6, 2004·3 cites·12 claims
- 0960US7759348B2Pyridazine derivatives and their use as therapeutic agentsXENON PHARMACEUTICALS INC·Filed 2008·Granted Jul 20, 2010·0 cites·12 claims
- 1059US2009197894A1Nicotinamide derivatives and their use as therapeutic agentsXENON PHARMACEUTICALS INC·Filed 2009·Application pending·0 cites
- 1157US7297523B2Human elongase genes and uses thereofXENON PHARMACEUTICALS INC·Filed 2001·Granted Nov 20, 2007·2 cites·5 claims
- 1256US2023073494A1Compositions and methods for generating synthetic lethality in tumorsENGINE BIOSCIENCES PTE LTD·Filed 2022·Application pending·0 cites
- 1356US2023078425A1Compositions and methods for generating synthetic lethality in tumorsENGINE BIOSCIENCES PTE LTD·Filed 2022·Application pending·0 cites
- 1456US2024398799A1Compositions and methods for generating synthetic lethality in tumorsENGINE BIOSCIENCES PTE LTD·Filed 2022·Application pending·0 cites
- 1555US8153636B2Pyridyl derivatives and their use as therapeutic agentsABREO MELWYN·Filed 2009·Granted Apr 10, 2012·0 cites·15 claims
- 1654US7294480B2High throughput screening assays using fatty acid synthetic enzymesXENON PHARMACEUTICALS INC·Filed 2004·Granted Nov 13, 2007·0 cites·13 claims
- 1754US2011021530A1Pyridazine derivatives and their use as therapeutic agents in the treatment of skin disordersXENON PHARMACEUTICALS INC·Filed 2009·Application pending·0 cites
- 1853US7605161B2Pyridyl derivatives and their use as therapeutic agentsXENON PHARMACEUTICALS INC·Filed 2004·Granted Oct 20, 2009·0 cites·7 claims
- 1952US2005119251A1Nicotinamide derivatives and their use as therapeutic agentsFiled 2004·Application pending·0 cites
- 2051US2023149415A1Methods and compositions for treating cancerENGINE BIOSCIENCES PTE LTD·Filed 2022·Application pending·0 cites
- 2150US8383628B2Pyridyl derivatives and their use as therapeutic agentsXENON PHARMACEUTICALS INC·Filed 2010·Granted Feb 26, 2013·0 cites·15 claims
- 2248US7964591B2Pyridazine derivatives and their use as therapeutic agentsNOVARTIS PHARMA AG·Filed 2010·Granted Jun 21, 2011·0 cites·14 claims
- 2347US2013079354A1Pyridyl derivatives and their use as therapeutic agentsABREO MELWYN·Filed 2012·Application pending·0 cites
- 2446US2009060900A1Methods for Screening Compounds That Modulate Lipid MetabolismXENON GENETICS INC·Filed 2007·Application pending·0 cites
- 2543US2008220500A1Human Elongase Genes, Uses Thereof, and Compounds for Modulating SameWINTHER MICHAEL DAVID·Filed 2007·Application pending·0 cites
- 2642US7256028B2Methods for screening compounds that modulate lipid metabolismXENON PHARMACEUTICALS INC·Filed 2001·Granted Aug 14, 2007·0 cites·6 claims
- 2740US4743554ARecombinant DNA expression vector encoding for foot and mouth disease virus proteinsBOOTHROYD JOHN C·Filed 1985·Granted May 10, 1988·13 cites·3 claims
- 2835US2004053234A1Polynucletides that control delta-6 desaturase genes and methods for identifying compounds for modulating delta-6 desaturaseFiled 2001·Application pending·0 cites
- 2929US2004146872A1Fat regulated genes, uses thereof and compounds for modulating sameFiled 2001·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Michael D. Winther files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →